Skip to main content

Bequant Expands Prime Services Range For Crypto Hedge Funds

Digital assets prime broker Bequant has added derivatives trading, separately managed accounts and an expanded OTC order book to its suite of resources.

“This expanded product offering is the natural evolution of our business line and puts Bequant  in pole position among the organisations vying for business in the highly competitive institutional asset management market,” said Bequant CEO George Zarya. “We are the only organisation to offer a full set of prime brokerage services including direct market access, instant transfers between exchanges and collateral management tools, cross margining and OTC lending, API and FIX access, colocation facility, single API connectivity options, algorithmic execution including Smart Order Routing all together under one umbrella.”

Bequant has partnered with exchanges including Deribit, Binance, Huobi and more to give cryptocurrency traders a wider variety of options for trading derivatives contracts (offered through Bequant prime brokerage) and an expanded OTC order book enables institutions to execute large trades with post-trade settlement  similar to how block trades are carried out in traditional markets. The introduction of SMAs enables portfolio managers to manage assets for sophisticated investors in customized buckets that are separate from larger funds or strategies. They are a cost effective, vital service that have long been available in traditional assets and should make digital assets even more appealing to a wider variety of participants seeking a familiar investment vehicle in a nascent market.

“Separately managed accounts have long been a hallmark of traditional asset management businesses,” said Alex Mascioli, head of institutional services at Bequant. “Adding this option to our industry leading prime brokerage offering comes as a result of client demand and is a key part of our business heading into the coming year.”


© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.